Expertise in
1
conditions

Thomas H. Schmitz

Essen, NW, DE 
Expertise in
1
conditions
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Thomas Schmitz practices in Essen, Germany. Mr. Schmitz is highly rated in 1 condition, according to our data. His top areas of expertise are Mitral Valve Regurgitation, Coronary Heart Disease, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Stent Placement.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Essen, NW, Germany
Other Locations
Ulm, BW 89075, Germany
Aachen, NW 52062, Germany
Augsburg, BY, Germany
Heidelberg, BW, Germany
Bonn, NW 53121, Germany
Duisburg, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Device
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Evaluation of a Sirolimus Eluting Bioadaptor as Compared to a Zotarolimus Eluting Stent in De Novo Native Coronary Arteries ELX-CL-1805
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Enrollment Status: Active_not_recruiting
Publish Date: January 01, 2025
Intervention Type: Device
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
A Prospective, Randomized, Multi-center Study to Assess the Safety of the Orsiro Mission Stent Compared to the Resolute Onyx Stent in Subjects at High Risk for Bleeding in Combination With 1-month Dual Antiplatelet Therapy (DAPT)
Enrollment Status: Completed
Publish Date: June 07, 2024
Intervention Type: Device
Study Phase: Phase 4
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2023
Intervention Type: Device
Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER IV Study
Clinical Investigation Plan (CIP) for Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER IV Study
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Enrollment Status: Completed
Publish Date: November 19, 2021
Intervention Type: Device
XIENCE 28 Global Study
XIENCE 28 Global Study
Enrollment Status: Completed
Publish Date: March 04, 2021
Intervention Type: Drug, Device
Study Phase: Not Applicable
Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association With Short-term Single Antiplatelet Therapy in Patients With Coronary Artery Disease With an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy
Prospective, Multi-centre, Randomized, Parallel Comparison to Evaluate the Safety and Efficacy of the Abluminal Sirolimus Coated Bio-engineered Stent (COMBO Stent) in Association With Short-term Single Antiplatelet Therapy in Patients With Coronary Artery Disease With an Indication for Chronic Oral Anticoagulant Therapy as Compared to a Guidelines-based Strategy
Enrollment Status: Withdrawn
Publish Date: February 20, 2017
Intervention Type: Device, Drug
Study Phase: Phase 4
View 10 Less Clinical Trials

67 Total Publications

Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis.
Patterns of Restenosis After Left Main Bifurcation Single- or Dual-Stenting: An EBC MAIN Trial Subanalysis.
Journal: Circulation. Cardiovascular interventions
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schmitz's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile